Arvinas (ARVN) Other Working Capital Changes (2017 - 2026)

Arvinas' (ARVN) quarterly Other Working Capital Changes came in at -$15.6 million in Q1 2026, down 3020.0% year-on-year from $534246.6 in Q1 2025, and up 93.53% quarter-over-quarter from -$241.0 million in Q4 2025.

Arvinas (ARVN) Other Working Capital Changes (2017 - 2026) Analysis & Trends

Arvinas' Other Working Capital Changes history runs 10 years deep, the most recent figure standing at -$15.6 million for Q1 2026.

  • On a quarterly basis, Other Working Capital Changes fell 3020.0% year-over-year to -$15.6 million in Q1 2026; TTM through Mar 2026 was -$257.7 million, a 155.15% decrease from a year earlier, with the FY2025 full-year figure at -$242.6 million, down 140.2% from the prior year.
  • Other Working Capital Changes advanced to -$15.6 million in Q1 2026 per ARVN's latest filing, from -$241.0 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $4.1 million in Q2 2024 and bottomed at -$6.9 million in Q1 2023.
  • The 5-year median for Other Working Capital Changes is $400000.0 (2024), against an average of -$588235.3.
  • Across the five-year window, Other Working Capital Changes slumped 18175.0% in 2023 and surged 10200.0% in 2024, its largest moves.
  • Year by year, Other Working Capital Changes stood at -$400000.0 in 2022, then slumped by 18175.0% to -$73.1 million in 2023, then tumbled by 35.98% to -$99.4 million in 2024, then plunged by 142.45% to -$241.0 million in 2025, then surged by 93.53% to -$15.6 million in 2026.
  • Per Business Quant, the three latest ARVN Other Working Capital Changes figures stand at -$15.6 million (Q1 2026), -$241.0 million (Q4 2025), and $209.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Arvinas 519.68 Mn -95.22 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 600,000.00
Mar 31, 2026 600,000.00
Mar 31, 2026 600,000.00
Dec 31, 2025 -3.00 Mn
Dec 31, 2025 -3.00 Mn
Dec 31, 2025 -3.00 Mn
Sep 30, 2025 -5.40 Mn
Sep 30, 2025 -5.40 Mn
Sep 30, 2025 -5.40 Mn
Jun 30, 2025 400,000.00
Jun 30, 2025 400,000.00
Jun 30, 2025 400,000.00
Mar 31, 2025 2.70 Mn
Mar 31, 2025 2.70 Mn
Mar 31, 2025 2.70 Mn
Dec 31, 2024 600,000.00
Dec 31, 2024 600,000.00
Dec 31, 2024 600,000.00
Sep 30, 2024 400,000.00
Sep 30, 2024 400,000.00